Theranostic nanomedicine for cancer.

Multimodality imaging probes: design and challenges. Chem Rev (2010) 2.61

Targeted hyperthermia using metal nanoparticles. Adv Drug Deliv Rev (2009) 2.12

Theranostic nanoshells: from probe design to imaging and treatment of cancer. Acc Chem Res (2011) 2.10

The big picture on nanomedicine: the state of investigational and approved nanomedicine products. Nanomedicine (2012) 1.83

Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy. Acc Chem Res (2011) 1.69

Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles. Cancer (2010) 1.54

Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51

In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring. Br J Cancer (2009) 1.51

Molecular imaging and therapy of cancer with radiolabeled nanoparticles. Nano Today (2009) 1.47

Molecular imaging with theranostic nanoparticles. Acc Chem Res (2011) 1.41

Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood) (2008) 1.33

Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics. Theranostics (2014) 1.29

Liposomes as nanomedical devices. Int J Nanomedicine (2015) 1.29

Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem Commun (Camb) (2009) 1.24

MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm (2010) 1.20

Recent progress in nanomedicine: therapeutic, diagnostic and theranostic applications. Curr Opin Biotechnol (2013) 1.19

Biomarkers in the age of omics: time for a systems biology approach. OMICS (2011) 1.13

Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines. Lasers Surg Med (2011) 1.11

Lipid- and polymer-based nanostructures for cancer theranostics. Theranostics (2012) 1.09

Non-invasive cell tracking in cancer and cancer therapy. Curr Top Med Chem (2010) 1.07

Toward carbon-nanotube-based theranostic agents for microwave detection and treatment of breast cancer: enhanced dielectric and heating response of tissue-mimicking materials. IEEE Trans Biomed Eng (2010) 1.06

Future Perspectives of Radionanomedicine Using the Novel Micelle-Encapsulation Method for Surface Modification. Nucl Med Mol Imaging (2015) 1.06

Photodynamic nanomedicine in the treatment of solid tumors: perspectives and challenges. J Control Release (2013) 1.05

Optimization of 5-flurouracil solid-lipid nanoparticles: a preliminary study to treat colon cancer. Int J Med Sci (2010) 1.03

pH-responsive polymeric sirna carriers sensitize multidrug resistant ovarian cancer cells to doxorubicin via knockdown of polo-like kinase 1. Mol Pharm (2010) 1.00

Iron oxide decorated MoS2 nanosheets with double PEGylation for chelator-free radiolabeling and multimodal imaging guided photothermal therapy. ACS Nano (2015) 0.99

Modular polymer-caged nanobins as a theranostic platform with enhanced magnetic resonance relaxivity and pH-responsive drug release. Angew Chem Int Ed Engl (2010) 0.98

Cyclooxgenase-2 inhibiting perfluoropoly (ethylene glycol) ether theranostic nanoemulsions-in vitro study. PLoS One (2013) 0.98

Quantum dots as a platform for nanoparticle drug delivery vehicle design. Adv Drug Deliv Rev (2012) 0.97

Will nanotechnology influence targeted cancer therapy? Semin Radiat Oncol (2011) 0.95

Design Strategies for Fluorescent Biodegradable Polymeric Biomaterials. J Mater Chem B Mater Biol Med (2013) 0.94

In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer. Theranostics (2012) 0.93

Multiphoton microscopy of transdermal quantum dot delivery using two photon polymerization-fabricated polymer microneedles. Faraday Discuss (2011) 0.92

Tumor-targeted drug delivery with aptamers. Curr Med Chem (2011) 0.91

Identifying early events of gene expression in breast cancer with systems biology phylogenetics. Cytogenet Genome Res (2013) 0.88

Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. Int J Nanomedicine (2011) 0.88

Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.86

Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. Chem Rev (2015) 0.85

Nanodevices in diagnostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2010) 0.84

Fluorescence imaging enabled biodegradable photostable polymeric micelles. Adv Healthc Mater (2013) 0.84

Personalized nanomedicine advancements for stem cell tracking. Adv Drug Deliv Rev (2012) 0.84

A MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancer. Int J Nanomedicine (2012) 0.83

Physical energy for drug delivery; poration, concentration and activation. Adv Drug Deliv Rev (2013) 0.82

A novel preparation method for drug nanocrystals and characterization by ultrasonic spray-assisted electrostatic adsorption. Int J Nanomedicine (2013) 0.81

Recent development of silica nanoparticles as delivery vectors for cancer imaging and therapy. Nanomedicine (2013) 0.81

Applications of nanoparticles for diagnosis and therapy of cancer. Br J Radiol (2015) 0.81

Label-free CEST MRI Detection of Citicoline-Liposome Drug Delivery in Ischemic Stroke. Theranostics (2016) 0.79

Multifunctional nanoassemblies of block copolymers for future cancer therapy. Sci Technol Adv Mater (2010) 0.77

Covalent IR820-PEG-diamine nanoconjugates for theranostic applications in cancer. Int J Nanomedicine (2014) 0.77

Fluorophore labeling of core-crosslinked polymeric micelles for multimodal in vivo and ex vivo optical imaging. Nanomedicine (Lond) (2015) 0.77

Theranostics: A treasured tailor for tomorrow. J Pharm Bioallied Sci (2014) 0.77

Nanoparticles in sentinel lymph node assessment in breast cancer. Cancers (Basel) (2010) 0.77

Glycol chitosan-based fluorescent theranostic nanoagents for cancer therapy. Mar Drugs (2014) 0.76

Biosafe nanoscale pharmaceutical adjuvant materials. J Biomed Nanotechnol (2014) 0.76

CEST theranostics: label-free MR imaging of anticancer drugs. Oncotarget (2016) 0.76

Citrate-Based Biomaterials and Their Applications in Regenerative Engineering. Annu Rev Mater Res (2015) 0.76

A Novel Nanoprobe for Multimodal Imaging Is Effectively Incorporated into Human Melanoma Metastatic Cell Lines. Int J Mol Sci (2015) 0.75

Development of a large peptoid-DOTA combinatorial library. Biopolymers (2016) 0.75

Dual-Responsive Molecular Probe for Tumor Targeted Imaging and Photodynamic Therapy. Theranostics (2017) 0.75

What is the role of curvature on the properties of nanomaterials for biomedical applications? Wiley Interdiscip Rev Nanomed Nanobiotechnol (2015) 0.75

Iron Oxide Nanoparticles Coated with a Phosphorothioate Oligonucleotide and a Cationic Peptide: Exploring Four Different Ways of Surface Functionalization. Nanomaterials (Basel) (2015) 0.75

In Vivo Targeting of Metabolically Labeled Cancers with Ultra-Small Silica Nanoconjugates. Theranostics (2016) 0.75

Nanomaterials incorporated ultrasound contrast agents for cancer theranostics. Cancer Biol Med (2016) 0.75

The evolving landscape of drug products containing nanomaterials in the United States. Nat Nanotechnol (2017) 0.75

Preparation, characterization, and potential application of chitosan, chitosan derivatives, and chitosan metal nanoparticles in pharmaceutical drug delivery. Drug Des Devel Ther (2016) 0.75

Nanomedicine approaches for corneal diseases. J Funct Biomater (2015) 0.75

Real-time and label-free monitoring of nanoparticle cellular uptake using capacitance-based assays. Sci Rep (2016) 0.75

Remotely Triggered Nano-Theranostics For Cancer Applications. Nanotheranostics (2017) 0.75

The Emerging Role of Nanotechnology in Cell and Organ Transplantation. Transplantation (2016) 0.75

Nanoscale "fluorescent stone": Luminescent Calcium Fluoride Nanoparticles as Theranostic Platforms. Theranostics (2016) 0.75

Gastrointestinal cancers in the era of theranostics: Updates and future perspectives. World J Gastroenterol (2015) 0.75

Smart Nanoscale Drug Delivery Platforms from Stimuli-Responsive Polymers and Liposomes. Macromolecules (2013) 0.75

Effects of radiofrequency radiation in the presence of gold nanoparticles for the treatment of renal cell carcinoma. J Renal Inj Prev (2016) 0.75

Nanomedicine as an innovative therapeutic strategy for pediatric cancer. Pediatr Surg Int (2015) 0.75

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett (2006) 3.94

Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Control Release (2004) 2.43

An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci U S A (2007) 1.92

Functionalized micellar systems for cancer targeted drug delivery. Pharm Res (2007) 1.90

cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew Chem Int Ed Engl (2004) 1.63

In vivo angiogenesis imaging of solid tumors by alpha(v)beta(3)-targeted, dual-modality micellar nanoprobes. Exp Biol Med (Maywood) (2010) 1.59

Nanonization strategies for poorly water-soluble drugs. Drug Discov Today (2010) 1.46

Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. Angew Chem Int Ed Engl (2011) 1.37

Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood) (2008) 1.33

In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. Cancer Res (2009) 1.32

Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy. Cancer Res (2010) 1.26

An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis. Cancer Res (2012) 1.24

Polymeric nanomedicine for cancer MR imaging and drug delivery. Chem Commun (Camb) (2009) 1.24

Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation. Cancer Res (2010) 1.20

MRI-visible micellar nanomedicine for targeted drug delivery to lung cancer cells. Mol Pharm (2010) 1.20

Zinc ferrite nanoparticles as MRI contrast agents. Chem Commun (Camb) (2008) 1.18

Overcoming endosomal barrier by amphotericin B-loaded dual pH-responsive PDMA-b-PDPA micelleplexes for siRNA delivery. ACS Nano (2011) 1.17

Beta-lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells. J Control Release (2007) 1.15

Modeling particle shape-dependent dynamics in nanomedicine. J Nanosci Nanotechnol (2011) 1.14

Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration (2010) 1.13

Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels. Clin Cancer Res (2005) 1.13

Multicolored pH-tunable and activatable fluorescence nanoplatform responsive to physiologic pH stimuli. J Am Chem Soc (2012) 1.13

Attenuation of acute lung inflammation induced by cigarette smoke in CXCR3 knockout mice. Respir Res (2008) 1.10

Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes. Pharm Res (2003) 1.10

Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci (2008) 1.09

Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers. Mol Cancer Ther (2013) 1.08

MRI-visible polymeric vector bearing CD3 single chain antibody for gene delivery to T cells for immunosuppression. Biomaterials (2009) 1.08

A prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in mice. Respir Res (2010) 1.07

Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy. Clin Cancer Res (2011) 1.06

The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Biomaterials (2010) 1.06

Synthesis and stabilization of FeCo nanoparticles. J Am Chem Soc (2007) 1.06

Antitumor efficacy and local distribution of doxorubicin via intratumoral delivery from polymer millirods. J Biomed Mater Res A (2007) 1.05

Ultra-pH-sensitive nanoprobe library with broad pH tunability and fluorescence emissions. J Am Chem Soc (2014) 1.04

Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy. Clin Cancer Res (2009) 1.04

Shape-specific polymeric nanomedicine: emerging opportunities and challenges. Exp Biol Med (Maywood) (2011) 1.01

Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1. Cancer Biol Ther (2005) 1.01

Folate-functionalized polymeric micelles for tumor targeted delivery of a potent multidrug-resistance modulator FG020326. J Biomed Mater Res A (2008) 1.00

Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation. J Biomed Mater Res A (2006) 1.00

Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation. Int J Radiat Oncol Biol Phys (2005) 0.97

Combined radiofrequency ablation and doxorubicin-eluting polymer implants for liver cancer treatment. J Biomed Mater Res A (2007) 0.97

Investigation of In Vivo Targeting Kinetics of α(v)β(3)-Specific Superparamagnetic Nanoprobes by Time-Resolved MRI. Theranostics (2011) 0.96

Infrared characterization of interfacial Si-O bond formation on silanized flat SiO2/Si surfaces. Langmuir (2010) 0.96

Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation. J Pharm Sci (2006) 0.95

Doxorubicin and beta-lapachone release and interaction with micellar core materials: experiment and modeling. Exp Biol Med (Maywood) (2007) 0.93

Photoactivation switch from type II to type I reactions by electron-rich micelles for improved photodynamic therapy of cancer cells under hypoxia. J Control Release (2011) 0.93

Characterization of lung cancer by amide proton transfer (APT) imaging: an in-vivo study in an orthotopic mouse model. PLoS One (2013) 0.92

Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy. Theranostics (2013) 0.91

Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro. Int J Nanomedicine (2006) 0.91

Attenuation of antigen-induced airway hyperresponsiveness and inflammation in CXCR3 knockout mice. Respir Res (2011) 0.89

Quantification of in vivo doxorubicin transport from PLGA millirods in thermoablated rat livers. J Control Release (2003) 0.89

The role of CXCR3 in the induction of primary biliary cirrhosis. Clin Dev Immunol (2011) 0.89

Nanoscopic micelle delivery improves the photophysical properties and efficacy of photodynamic therapy of protoporphyrin IX. J Control Release (2011) 0.89

Ultrasensitive protein detection using lithographically defined Si multi-nanowire field effect transistors. Lab Chip (2011) 0.89

Mornings with Art, lessons learned: feedback regulation, restriction threshold biology, and redundancy govern molecular stress responses. J Cell Physiol (2006) 0.89

Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med Genet (2011) 0.88

Multi-chromatic pH-activatable 19F-MRI nanoprobes with binary ON/OFF pH transitions and chemical-shift barcodes. Angew Chem Int Ed Engl (2013) 0.88

Polymeric micelle nanoparticles for photodynamic treatment of head and neck cancer cells. Otolaryngol Head Neck Surg (2010) 0.87

Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. J Control Release (2007) 0.86

Interactions between self-assembled polyelectrolyte shells and tumor cells. J Biomed Mater Res A (2005) 0.86

Combined modeling and experimental approach for the development of dual-release polymer millirods. J Control Release (2002) 0.86

A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors. Mol Pharm (2012) 0.85

Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants. Med Biol Eng Comput (2008) 0.85

Fabrication of polymeric nanorods using bilayer nanoimprint lithography. Small (2009) 0.83

Phosphatidylserine-targeted molecular imaging of tumor vasculature by magnetic resonance imaging. J Biomed Nanotechnol (2014) 0.82

A mechanistic model of controlled drug release from polymer millirods: effects of excipients and complex binding. J Control Release (2007) 0.82

Silicon multi-nanochannel FETs to improve device uniformity/stability and femtomolar detection of insulin in serum. Biosens Bioelectron (2013) 0.82

Membrane-encased polymer millirods for sustained release of 5-fluorouracil. J Biomed Mater Res (2002) 0.81

Activated expression of the chemokine Mig after chemotherapy contributes to chemotherapy-induced bone marrow suppression and lethal toxicity. Blood (2012) 0.81

A Novel Strategy for Surface Modification of Superparamagnetic Iron Oxide Nanoparticles for Lung Cancer Imaging. J Mater Chem (2009) 0.81

Altered Th1/Th2 commitment contributes to lung senescence in CXCR3-deficient mice. Exp Gerontol (2013) 0.80

Noninvasive monitoring of local drug release using X-ray computed tomography: optimization and in vitro/in vivo validation. J Pharm Sci (2003) 0.80

A novel class of polymeric pH-responsive MRI CEST agents. Chem Commun (Camb) (2013) 0.80

Chaotropic-anion-induced supramolecular self-assembly of ionic polymeric micelles. Angew Chem Int Ed Engl (2014) 0.80

Effect of fibrous capsule formation on doxorubicin distribution in radiofrequency ablated rat livers. J Biomed Mater Res A (2004) 0.79

In vivo optical imaging of folate receptor-β in head and neck squamous cell carcinoma. Laryngoscope (2014) 0.79

Comparison of doxorubicin concentration profiles in radiofrequency-ablated rat livers from sustained- and dual-release PLGA millirods. Pharm Res (2004) 0.78

Characteristics of sensorineural hearing loss in children with inner ear anomalies. Am J Otolaryngol (2005) 0.78

Characterization and optimization of mTHPP nanoparticles for photodynamic therapy of head and neck cancer. Otolaryngol Head Neck Surg (2011) 0.78

Genetic variations of the CDC2L2 gene are associated with type 2 diabetes in a Han Chinese cohort. Diabetes Metab Res Rev (2007) 0.78

Noninvasive monitoring of local drug release in a rabbit radiofrequency (RF) ablation model using X-ray computed tomography. J Control Release (2002) 0.78

Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations. J Magn Reson (2011) 0.77

Prodrug strategy to achieve lyophilizable, high drug loading micelle formulations through diester derivatives of β-Lapachone. Adv Healthc Mater (2014) 0.77

Highly brominated metabolites from marine red alga Laurencia similis inhibit protein tyrosine phosphatase 1B. Bioorg Med Chem Lett (2010) 0.77

Off-resonance saturation magnetic resonance imaging of superparamagnetic polymeric micelles. Conf Proc IEEE Eng Med Biol Soc (2009) 0.76

Quantitative computed tomography analysis of local chemotherapy in liver tissue after radiofrequency ablation. Acad Radiol (2004) 0.75

16. 10-year micelle journey: lessons and future outlook: Original research article: Micellar carriers based on block copolymers of poly (ε-caprolactone) poly (ethylene glycol) for doxorubicin delivery (2004). J Control Release (2014) 0.75

Erratum: Molecular basis of cooperativity in pH-triggered supramolecular self-assembly. Nat Commun (2016) 0.75

Solution-based synthesis of quaternary Cu-In-Zn-S nanobelts with tunable composition and band gap. Chem Commun (Camb) (2011) 0.75

Gold-catalyzed selective oxidation of 4-oxahepta-1,6-diynes to 2H-pyran-3(6H)-ones and chromen-3(4H)-ones via β-gold vinyl cation intermediates. Chem Commun (Camb) (2015) 0.75

Two new triterpenoids from Photinia serrulata. Molecules (2007) 0.75

Carboline alkaloids from Psammosilene tunicoides and their cytotoxic activities. Planta Med (2012) 0.75

[Epidemiological survey of the incidence of bronchial asthma in occupational populations in Beijing area]. Zhonghua Jie He He Hu Xi Za Zhi (2002) 0.75

Simultaneous identification of multiple celangulins from the root bark of Celastrus angulatus using high-performance liquid chromatography-diode array detector-electrospray ionisation-tandem mass spectrometry. Phytochem Anal (2011) 0.75

X-ray computed tomography methods for in vivo evaluation of local drug release systems. IEEE Trans Med Imaging (2002) 0.75